Medicare Enrolled
Dr. Sherief Kamel, M.D.
Endocrinology · Panama City, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kamel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kamel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kamel
Dr. Sherief Kamel is an endocrinology specialist in Panama City, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kamel performed 11,970 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kamel received a total of $52,164 from 53 pharmaceutical and/or device companies across 494 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kamel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in FL
$52,164 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 92200 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗11,970
Medicare services
Top 7% in FL for endocrinology
Not available
Unique patients (not deduplicated)
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,080 | $18 | $50 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
1,440 | $36 | $77 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,431 | $35 | $89 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
934 | $47 | $63 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
831 | $30 | $63 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
671 | $88 | $164 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
621 | $77 | $171 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
489 | $36 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
377 | $65 | $113 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
280 | $9 | $25 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
223 | $27 | $100 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
117 | $11 | $30 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
116 | $104 | $500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
111 | $128 | $221 |
| Liver stiffness measurement A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring. |
63 | $23 | $56 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
60 | $14 | $27 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
39 | $63 | $150 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
30 | $57 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $101 | $250 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
19 | $88 | $182 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $103 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$52,164
Total received (2018-2024)
Avg $7,452/year across 7 years
Top 10% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
494
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,027
2023
$5,959
2022
$5,176
2021
$4,459
2020
$6,228
2019
$20,623
2018
$8,691
Payments by company (2024)
Medtronic, Inc.
$135
Novo Nordisk Inc
$133
Abbott Laboratories
$72
Dexcom, Inc.
$69
Amgen Inc.
$68
ABBVIE INC.
$67
Novartis Pharmaceuticals Corporation
$63
BETA BIONICS, INC.
$60
Tandem Diabetes Care, Inc.
$59
Lilly USA, LLC
$59
Radius Health, Inc.
$42
Ascensia Diabetes Care Us Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$34
RECORDATI_RARE_DISEASES_INC.
$32
Kyowa Kirin, Inc.
$28
Astellas Pharma US Inc
$26
AstraZeneca Pharmaceuticals LP
$16
IBSA Pharma Inc.
$15
Amneal Pharmaceuticals LLC
$14
Top 3 companies account for 33.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$28,832
Lilly USA, LLC
$15,988
Novo Nordisk Inc
$1,336
Medtronic, Inc.
$717
Medtronic MiniMed, Inc.
$442
Amgen Inc.
$377
SANOFI-AVENTIS U.S. LLC
$341
Tandem Diabetes Care, Inc.
$336
Corcept Therapeutics
$294
Abbott Laboratories
$266
Dexcom, Inc.
$258
Horizon Therapeutics plc
$256
Bayer Healthcare Pharmaceuticals Inc.
$254
Merck Sharp & Dohme Corporation
$214
Nevro Corp.
$207
AstraZeneca Pharmaceuticals LP
$182
Bayer HealthCare Pharmaceuticals Inc.
$180
ABBVIE INC.
$172
Ultragenyx Pharmaceutical Inc.
$141
Insulet Corporation
$140
Merck Sharp & Dohme LLC
$110
Ascensia Diabetes Care Us Inc.
$82
Radius Health, Inc.
$63
Novartis Pharmaceuticals Corporation
$63
Averitas Pharma Inc.
$63
BETA BIONICS, INC.
$60
Kyowa Kirin, Inc.
$58
AbbVie Inc.
$58
Senseonics, Incorporated
$52
IBSA Pharma Inc.
$50
Esperion Therapeutics, Inc.
$47
Astellas Pharma US Inc
$44
Amneal Pharmaceuticals LLC
$41
Amarin Pharma Inc.
$40
RECORDATI_RARE_DISEASES_INC.
$32
Xeris Pharmaceuticals, Inc.
$32
KVK-Tech, Inc.
$29
Allergan Inc.
$26
Eisai Inc.
$24
Renalytix AI, Inc.
$23
DEXCOM, INC.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$22
Blueprint Medicines Corporation
$22
Tolmar, Inc.
$21
PFIZER INC.
$20
MannKind Corporation
$20
Acerus Pharmaceuticals Corporation
$18
GRT US Holding, Inc.
$17
OPKO Pharmaceuticals, LLC
$17
Vertical Pharmaceuticals, LLC
$15
Janssen Pharmaceuticals, Inc
$14
Kowa Pharmaceuticals America, Inc.
$13
Mannkind Corporation
$12
Top 3 companies account for 88.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BELSOMRA · CRYSVITA · Crysvita · Cryvista · DEXCOM G6 TRANSMITTER · DIVIGEL · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FIASP · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Lite system · GAVRETO · GUARDIAN SENSOR (3) · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LICART · Lenvima · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 670G System · Minimed 770G System · NEXLETOL · Natesto · Omnia · Omnipod · Ozempic · PREVNAR 20 · QULIPTA · QUTENZA · Qutenza · RAYALDEE · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · STEGLUJAN · SYNTHROID · TEPEZZA · TOUJEO · TRULICITY · Tirosint · Tymlos · UBRELVY · UNITHROID · Vascepa · Veozah · Wegovy · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
4
County median income
$70,188
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA GULF COAST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kamel is a clinical cardiology specialist, with above-average Medicare volume (top 7% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kamel experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Kamel performed 4,080 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kamel receive payments from pharmaceutical companies?
Yes. Dr. Kamel received a total of $52,164 from 53 companies across 494 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kamel's costs compare to other endocrinologists in Panama City?
Dr. Kamel's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kamel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Panama City
Browse endocrinologists in Panama City ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in FL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in FL
Which FL endocrinologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology